Public-registry trials using CaPre that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| A Phase 3 STudy of CaPRe In LOwering Very hiGh TriglYcerides (TRILOGY 1) | Grace Therapeutics Inc. | Hypertriglyceridemia | PHASE3 | 69 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →